| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Charles G Phillips III last filed a Form 4 in December 2019, as Director at NVCR. Charles G Phillips III's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 3,359 shares of NVCR. The NVCR filings lean toward selling, a net 173,245 shares.
Charles G Phillips III has 8 Form 4 filings on record from May 2017 to December 2019, all as Director at NovoCure (NVCR), 2017–2019.
The 22 reported transactions were 11 open-market sales, 6 option exercises, 4 option or other derivative awards and 1 stock award.
Counted by filing, the open-market trades come to no purchases and 4 sales worth about $9.0M.
The largest open-market sale was 95,100 shares of NVCR at an average $52.17 on May 29, 2019, about $5.0M.
Shares as reported in the last Form 4 for each company; the most recent is from December 2019. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2019 | NVCR Novocure Ltd | Director | Sell | 6,145 | $88.11 | $541,448.24 | -64.7% | |
| Aug 30, 2019 | NVCR Novocure Ltd | Director | Sale+OE | 22,000 | $91.14 | $2,005,117.64 | -69.8% | |
| May 29, 2019 | NVCR Novocure Ltd | Director | Sale+OE | 95,100 | $52.17 | $4,961,197.97 | -90.9% | |
| May 25, 2018 | NVCR Novocure Ltd | Director | Sale+OE | 50,000 | $30.30 | $1,515,075.00 | - |